Product Information
MILNACIPRAN HCL 12.5 MG TABLET is a generic product, priced at $0.4406 per EA under NDC 51991003406. Its NADAC has been published 5 times since Jul 22, 2026.
Heads up: FDA NDC-directory enrichment for this product is incomplete — manufacturer is not populated for this NDC in the latest weekly file. The NADAC price and history below are still authoritative; the surrounding metadata is limited to what the CMS publication itself carries.
MILNACIPRAN HCL 12.5 MG TABLET
NDC
51991003406
Classification
Generic
Effective Date
8/19/2026
Price Statistics
The NADAC for MILNACIPRAN HCL 12.5 MG TABLET has been published 5 times since Jul 22, 2026, and over the history we have for it it has risen 21.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4406 per EA |
|---|---|
| All-time high | $0.4406 (Aug 19, 2026) |
| All-time low | $0.3626 (Jul 22, 2026) |
| 52-week high | $0.4406 |
| 52-week low | $0.3626 |
| Median price | $0.3626 |
| Average price | $0.3782 |
| Largest weekly change | +21.5% (Aug 19, 2026) |
| Weeks tracked | 5 |
| Tracking since | Jul 22, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the drug market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MILNACIPRAN HCL 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MILNACIPRAN HCL 12.5 MG TABLET is $0.4406 per EA (NDC 51991003406), effective Aug 19, 2026.
How has the price of MILNACIPRAN HCL 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MILNACIPRAN HCL 12.5 MG TABLET has risen 21.5%. It has been tracked across 5 weekly CMS publications since Jul 22, 2026.
What are the highest and lowest recorded NADAC prices for MILNACIPRAN HCL 12.5 MG TABLET?
Since Jul 22, 2026, the NADAC for MILNACIPRAN HCL 12.5 MG TABLET has ranged from a low of $0.3626 (Jul 22, 2026) to a high of $0.4406 (Aug 19, 2026), with a median of $0.3626 per EA.
Are there cheaper alternatives to MILNACIPRAN HCL 12.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MILNACIPRAN HCL 12.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.